Posts by: Iqra Mumal, MSc

Iqra Mumal, MSc

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

November 13, 2018

Low-dose Use of Chemotherapy, Lysodren, May Treat Children Ineligible for Surgery, Study Reports

News

Low-dose Lysodren (mitotane) can help restore growth rates and pubertal development, and lower body mass index (BMI) in children with Cushing’s disease who are not eligible for pituitary surgery. ... Read more

September 6, 2018

Cabergoline Is Alternative Option for Treatment of Cushing’s Disease, Meta-analysis Suggests

News

Medical therapy using cabergoline is an option for treating patients with persistent or recurrent Cushing’s disease after transsphenoidal surgery, new research from India shows. The study, “Effect of cabergoline monotherapy ... Read more

September 4, 2018

Minimally Invasive Approaches Lead to High Remission Rates in Children

News

Minimally invasive diagnostic methods and transnasal surgery may lead to remission in nearly all children with Cushing’s disease, while avoiding more aggressive approaches such as radiation or removal of ... Read more

August 9, 2018

Korlym as Good as Adrenal Surgery for Treating Ectopic Cushing’s Syndrome, Study Finds

News

Korlym (mifepristone) is effective for the treatment of ectopic Cushing’s syndrome patients, with survival rates comparable to patients who undergo bilateral adrenalectomy (removal of the adrenal glands), new research ... Read more

July 19, 2018

Cushing’s Patients with USP8-mutant Tumors Have More Frequent Relapses Sooner After Surgery, Study Shows

News

Patients with Cushing’s disease whose pituitary tumors bear mutations in the USP8 gene are more likely to experience recurrence, and develop them sooner after surgery, a new study shows. The study, ... Read more

July 17, 2018

Laparoscopic Adrenalectomy Is Effective and Safe for Treating Cushing’s Syndrome, Study Finds

News

Laparoscopic adrenalectomy — the removal of the adrenal glands through tiny holes in the abdomen — is a safe and effective method for treating certain patients with Cushing’s syndrome, ... Read more

July 10, 2018

Fluorescent Dye Significantly Aids Surgeons in Laparoscopic Adrenalectomy

News

A fluorescent dye that helps surgeons accurately identify anatomical structures is safe and may help guide laparoscopic procedures to remove the adrenal glands, a new study shows. The study, ... Read more

July 5, 2018

Temozolomide Partially Effective for Aggressive Pituitary Tumors, But More Study Needed, Case Report Shows

News

Temozolomide — an oral chemotherapy treatment — may be partially effective for Cushing’s disease patients with aggressive pituitary tumors that do not respond to conventional therapies, a case report suggests. ... Read more

July 3, 2018

Cushing’s Syndrome Sometimes Caused by Abnormal Receptors on Adrenal Glands, Case Report Shows

News

In rare cases, abnormal receptors on the adrenal glands can cause excess cortisol and Cushing’s syndrome, according to a case report. Identifying these receptors can allow physicians to treat ... Read more

June 26, 2018

Ectopic Cushing’s Syndrome Could Be Divided Into Two Subtypes, Researchers Propose

News

Patients with a form of Cushing’s syndrome caused by a tumor outside the pituitary gland that produces excess adrenocorticotropic hormone (ACTH) could be classified into two subgroups, researchers suggest in ... Read more